Historical
CLSI EP07-A2
Interference Testing in Clinical Chemistry; Approved Guideline - Second Edition
This document provides background information, guidance, and experimental procedures for investigating, identifying, and characterizing the effects of interfering substances on clinical chemistry test results. The U.S. Food and Drug Administration (FDA) has evaluated and recognized this approved-level consensus standard for use in satisfying a regulatory requirement
CONTENT PROVIDER
Clinical And Laboratory Standards Institute [clsi]
Clinical And Laboratory Standards Institute [clsi]